Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1426]

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk...

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )

Comment: POLAR gene profile can identify which patients can safely avoid...

Prof Christos Markopoulos- National and Kapodistrian University of Athens...

Updates from TAILORx and RxPONDER: Implications for practice

Prof Christos Markopoulos and Dr Kevin Kalinsky

Updates from TAILORx and RxPONDER: Implications for practice ( Prof Christos Markopoulos and Dr Kevin Kalinsky )

Genetic profiling identifies patients who can omit radiation therapy after...

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

What is required to advance data ethics, data sharing, and Open Science across...

Dr Priya Kumari - Regional Cancer Centre Trivandrum, Trivandrum, India

What is required to advance data ethics, data sharing, and Open Science across LMICs ( Dr Priya Kumari - Regional Cancer Centre Trivandrum, Trivandrum, India )

HER2DX confirms the ability of the test to predict long-term survival and...

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

Initiatives in monitoring of cancer screening in low- and middle-income...

Dr Partha Basu - International Agency for Research on Cancer, Lyon, France

Initiatives in monitoring of cancer screening in low- and middle-income countries ( Dr Partha Basu - International Agency for Research on Cancer, Lyon, France )

Cancer control in Latin America

Adolfo Dammert - Liga Contra el Cáncer, Pueblo Libre, Perú

Cancer control in Latin America ( Adolfo Dammert - Liga Contra el Cáncer, Pueblo Libre, Perú )

Assessment of cervical and breast cancer screening in Latin America and...

Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France

Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project ( Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France )

Genomic testing: Australian model for unlocking the potential of precision...

Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst...

Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems ( Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst, Australia )

Choosing the control arm/standard of care in clinical trials

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Choosing the control arm/standard of care in clinical trials ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

ESMO 2022: Breast and ovarian trial analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

More from ecancer